These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8297894)

  • 1. [Prophylactic effects of trimethoprim-sulfamethoxazole in Toxoplasma-infected mice].
    Lee YH; Lee DY; Shin DW
    Korean J Parasitol; 1993 Dec; 31(4):363-70. PubMed ID: 8297894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
    Grossman PL; Remington JS
    Am J Trop Med Hyg; 1979 May; 28(3):445-55. PubMed ID: 453442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nitazoxanide and spiramycin metronidazole combination in acute experimental toxoplasmosis.
    FarahatAllam A; Shehab AY; Fawzy Hussein Mogahed NM; Farag HF; Elsayed Y; Abd El-Latif NF
    Heliyon; 2020 Apr; 6(4):e03661. PubMed ID: 32322704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of L-citrulline adjunctive treatment of Toxoplasma gondii RH strain infection in a mouse model.
    Saad AE; Zoghroban HS; Ghanem HB; El-Guindy DM; Younis SS
    Acta Trop; 2023 Mar; 239():106830. PubMed ID: 36638878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
    Nguyen BT; Stadtsbaeder S
    Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of trimethoprim and sulphamethoxazole as monotherapy or in combination in the management of toxoplasmosis in murine models.
    Dumas JL; Pizzolato G; Pechère JC
    Int J Antimicrob Agents; 1999 Sep; 13(1):35-9. PubMed ID: 10563403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergetic potential of Lactobacillus delbrueckii and Lactobacillus fermentum probiotics in alleviating the outcome of acute toxoplasmosis in mice.
    Almallah TM; Khedr SI; El Nouby KA; Younis SS; Elazeem MA; Elmehy DA
    Parasitol Res; 2023 Apr; 122(4):927-937. PubMed ID: 36786888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain).
    Nguyen BT; Stadtsbaeder S
    Br J Pharmacol; 1985 Jul; 85(3):713-6. PubMed ID: 3875381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.
    Harper JS; London WT; Sever JL
    Am J Trop Med Hyg; 1985 Jan; 34(1):50-7. PubMed ID: 3970309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of Toxoplasma antigens and antibodies in mice infected with different strains of Toxoplasma gondii].
    Lee YH; Kim KY; Kang MS; Shin DW
    Korean J Parasitol; 1995 Sep; 33(3):201-10. PubMed ID: 8528627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.
    Chew WK; Segarra I; Ambu S; Mak JW
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1762-8. PubMed ID: 22271863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
    J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
    Grujić J; Djurković-Djaković O; Nikolić A; Klun I; Bobić B
    Int J Antimicrob Agents; 2005 Mar; 25(3):226-30. PubMed ID: 15737517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of trimethoprim and sulfamethoxazole in cerebrospinal fluid and serum in mares with and without a dimethyl sulfoxide pretreatment.
    Green SL; Mayhew IG; Brown MP; Gronwall RR; Montieth G
    Can J Vet Res; 1990 Apr; 54(2):215-22. PubMed ID: 2357657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
    Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA
    Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
    Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
    J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy.
    Bu LN; Chen HL; Chang CJ; Ni YH; Hsu HY; Lai HS; Hsu WM; Chang MH
    J Pediatr Surg; 2003 Apr; 38(4):590-3. PubMed ID: 12677572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-155 Expression and Butyrylcholinesterase Activity in the Liver Tissue of Mice Infected with Toxoplasma gondii (Avirulent and Virulent Strains).
    El-Sayad M; Abdel Rahman M; Hussein N; Abdel Aziz R; El-Taweel HA; Abd El-Latif N
    Acta Parasitol; 2021 Dec; 66(4):1167-1176. PubMed ID: 33840057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.
    DiRienzo AG; van Der Horst C; Finkelstein DM; Frame P; Bozzette SA; Tashima KT
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):89-94. PubMed ID: 11839141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA mmu-miR-511-5p: A promising Diagnostic Biomarker in Experimental Toxoplasmosis Using Different Strains and Infective Doses in Mice with Different Immune States Before and After Treatment.
    Mady RF; El-Temsahy MM; Issa YA; Zaghloul AS; Khedr SI
    Acta Parasitol; 2024 Jun; 69(2):1253-1266. PubMed ID: 38743178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.